share_log

Elevai Labs | 8-K: Current report

Elevai Labs | 8-K: Current report

Elevai Labs | 8-K:重大事件
美股SEC公告 ·  2024/11/23 06:01

牛牛AI助理已提取核心訊息

Elevai Labs Inc. announced a 1-for-200 reverse stock split effective November 27, 2024, aimed at maintaining compliance with Nasdaq's minimum bid price requirement of $1.00 per share. The split was approved by stockholders on August 12, 2024, and the board of directors on August 22, 2024.Under the split terms, every 200 shares of common stock will automatically consolidate into one share, with stockholders receiving one whole share in lieu of fractional shares. The company's trading symbol remains "ELAB" but with a new CUSIP number (28622K 203). Post-split, approximately 3.07 million shares of common stock will be outstanding.The company has adjusted its equity incentive plan, including the number of shares available for future grants and the exercise prices of outstanding stock options. VStock Transfer, LLC will serve as the exchange agent, though stockholders holding shares in brokerage accounts require no action. The move is part of Elevai's strategy to maintain Nasdaq listing compliance and enhance market visibility.
Elevai Labs Inc. announced a 1-for-200 reverse stock split effective November 27, 2024, aimed at maintaining compliance with Nasdaq's minimum bid price requirement of $1.00 per share. The split was approved by stockholders on August 12, 2024, and the board of directors on August 22, 2024.Under the split terms, every 200 shares of common stock will automatically consolidate into one share, with stockholders receiving one whole share in lieu of fractional shares. The company's trading symbol remains "ELAB" but with a new CUSIP number (28622K 203). Post-split, approximately 3.07 million shares of common stock will be outstanding.The company has adjusted its equity incentive plan, including the number of shares available for future grants and the exercise prices of outstanding stock options. VStock Transfer, LLC will serve as the exchange agent, though stockholders holding shares in brokerage accounts require no action. The move is part of Elevai's strategy to maintain Nasdaq listing compliance and enhance market visibility.
Elevai Labs Inc. 宣佈將於2024年11月27日進行1比200的反向股拆分,此舉旨在保持符合納斯達克每股最低買盤價格要求1.00美元的標準。該拆分於2024年8月12日獲得股東批准,並於2024年8月22日獲得董事會批准。根據拆分條款,每200股普通股將自動合併爲一股,股東將收穫一整股以替代碎股。公司的交易標的保持爲 "ELAB",但會有一個新的CUSIP號碼(2862.2萬 203)。拆分後,約307萬股普通股將流通在外。公司已調整其股權激勵計劃,包括未來授予的可用股份數量及已發行期權的行使價格。VStock Transfer, LLC 將擔任交易所代理,持有券商賬戶股份的股東無需採取任何行動。這一舉措是Elevai保持納斯達克上市合規性並提升市場可見性策略的一部分。
Elevai Labs Inc. 宣佈將於2024年11月27日進行1比200的反向股拆分,此舉旨在保持符合納斯達克每股最低買盤價格要求1.00美元的標準。該拆分於2024年8月12日獲得股東批准,並於2024年8月22日獲得董事會批准。根據拆分條款,每200股普通股將自動合併爲一股,股東將收穫一整股以替代碎股。公司的交易標的保持爲 "ELAB",但會有一個新的CUSIP號碼(2862.2萬 203)。拆分後,約307萬股普通股將流通在外。公司已調整其股權激勵計劃,包括未來授予的可用股份數量及已發行期權的行使價格。VStock Transfer, LLC 將擔任交易所代理,持有券商賬戶股份的股東無需採取任何行動。這一舉措是Elevai保持納斯達克上市合規性並提升市場可見性策略的一部分。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。